X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Molecular Cancer

期刊標題檢索 MOL CANCER 最新評論: The editor-in-chief of MC has many articles written by Chinese people... (2024-10-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Molecular Cancer]您好,您是該頁面的第 318280 位訪客。

期刊簡介
期刊名稱Molecular Cancer Molecular Cancer
LetPub Score
8.5
52 ratings
Rate

Reputation
8.6

Influence
8.3

Speed
8.7

期刊簡稱MOL CANCER
ISSN1476-4598
h-index103
CiteScore
CiteScoreSJRSNIPCiteScore Rank
54.908.2224.737
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q12 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q13 / 230
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Oncology
Q17 / 404

自引率 (2023-2024)2.20%自引率趨勢
掲載範囲
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
官方網站http://molecular-cancer.biomedcentral.com
在線稿件提交https://submission.nature.com/new-submission/12943/3
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2002
每年文章數165每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( EUR3990; USD4890; GBP3490; )
APC waiver:Check Notes
Other charges: No
Keywords: oncology、tumour biology、cancer antigens
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ14/313
ONCOLOGYSCIEQ110/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Molecular Cancer】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    TRENDS IN MOLECULAR MEDICINEH-index: 160

    CiteScore: 24.60
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1751993
    FASEB JOURNAL724613
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS659025
    NUCLEIC ACIDS RESEARCH555249
    JOURNAL OF BIOLOGICAL CHEMISTRY399558
    International Journal of Biological Sciences309535
    CELL302917
    GENETICS AND MOLECULAR RESEARCH257600
    ONCOGENE237152
    PLANT SCIENCE232200
  •  

    Molecular Cancer Molecular Cancer
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/40)
  [Molecular Cancer] 的評論撰寫評論
作者: 慈悲冬晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 18:18:11 評論於
How long did it take for the news to come later?
(0) 讚! | 慈悲冬晴

作者: Phoebe Law


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-23 09:37:27 評論於
I couldn't find enough reviewers for my paper either
(0) 讚! | Phoebe Law

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 08:16:26 評論於
I am also doing major revisions, raising about 60 questions, and currently supplementing experiments to improve experimental methods. May I ask what kind of tumor you are researching?
(0) 讚! | 魔都吉星

作者: 擒龙盼雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-10 15:34:20 評論於
Review speed: 3.0 | Submission hit rate: 5.0 
Emphasis on research direction: tumor
Experience sharing: 3 months major revision, raised more than 30 questions, need to supplement some experiments, currently still supplementing experiments. Can you please tell me the probability of being accepted after the major revision?
(0) 讚! | 擒龙盼雁

作者: 崇学小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-08 15:38:45 評論於
Editor appointed for a month already, is there such a situation... Feeling that the current submission interface is a bit different from what the seniors shared
(0) 讚! | 崇学小姐姐

作者: Leila Bernard


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-05 17:13:17 評論於
I am the 8th day directly showing 2 reviewers accepted
(0) 讚! | Leila Bernard

作者: 魔都吉星


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-31 21:48:54 評論於
Have you received it yet?
(0) 讚! | 魔都吉星

作者: 凌霄迎波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-31 20:16:07 評論於
I submitted it for review in just one day
(0) 讚! | 凌霄迎波

作者: 崇学小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-27 21:29:12 評論於
The current submission status is "Editor appointed"... There is no editor assigned as mentioned by the seniors. May I ask how many days it will take for review?
(0) 讚! | 崇学小姐姐

作者: 崇学小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-27 09:43:30 評論於
Can you share the status changes? Thank you, boss
(0) 讚! | 崇学小姐姐

作者: 凌霄迎波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 16:44:31 評論於
How long does it take to receive it after the repair?
(0) 讚! | 凌霄迎波

作者: 凌霄迎波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 13:35:39 評論於
Finally received after four months. I hope the magazine will get better and better
(0) 讚! | 凌霄迎波

作者: 崇学小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-22 18:35:15 評論於
How long does it take for a fast rejection? What is the status after the editor is appointed and the submission is sent for review?
(0) 讚! | 崇学小姐姐

作者: Esther Vaughan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-19 22:27:48 評論於
It's very difficult to get selected, definitely not the kind of level where you can just coast along. Without a solid amount of work, you'll basically be rejected immediately
(0) 讚! | Esther Vaughan

作者: 无名氏121


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-15 20:40:59 評論於
Since its inception, Chongqing Medical University has published a total of 10 articles, with no instances of multiple articles from the same department
(1) 讚! | 无名氏121

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-12 22:08:21 評論於
Certainly, building a reputation takes a long time to accumulate, but it can be destroyed in just a few articles
(0) 讚! | 泽语大叔

作者: 重阳悦爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-10 18:18:30 評論於
Indeed, many around me are quick to reject without hesitation, and it is not easy to share research on top of that
(0) 讚! | 重阳悦爱

作者: 南风怡嘉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-10 08:03:23 評論於
The quality of the articles currently is much worse than the domestic STTT
(0) 讚! | 南风怡嘉

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 20:41:27 評論於
Research focus: circRNA; tumors; epigenetic experiences: have been paying attention to the Research series articles of this journal for a year, and I am happy to see the editorial department discover problems and adjust directions. Currently, there has been a significant increase in the research direction and regional distribution of manuscript sources, and each issue is filled with a lot of excellent scientific research. Indeed, some work may still look inferior to the impact factor, but overall, I think it is steadily improving. I hope the journal will continue to improve!
(0) 讚! | 泽语大叔

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 13:47:32 評論於
It has been a year since the Research series articles of this journal received attention. The editorial team is happy to discover and adjust their direction, and the research direction and regional distribution of the current manuscripts have significantly improved compared to before. Each issue also contains a large amount of impressive research work. Although there are still some works that pale in comparison to the impact factor, overall the quality is steadily improving, and we hope the journal continues to get better!
(0) 讚! | 泽语大叔

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 13:21:22 評論於
It has been a year since the Research series articles of this journal have been attracting attention. The editorial department is happy to discover and adjust its direction even if there are problems. Currently, the research direction and geographical distribution of the manuscript sources have been greatly improved compared to before, and each issue is filled with plenty of impressive scientific research work. Admittedly, some work still seems to fall short of the impact factor, but overall, things are moving in a positive direction. I hope the journal continues to improve!
(0) 讚! | 泽语大叔

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 11:41:13 評論於
It has been a year since the Research series articles of this journal have been in focus. The editorial team is happy to make adjustments and changes to the direction, even if problems are discovered. Currently, there has been a significant increase in the research direction and regional distribution of submissions compared to before, and each issue is filled with a large number of impressive research works. Admittedly, some works still seem to fall short of the impact factor, but overall it is steadily improving. Hoping for the magazine to become even better!
(0) 讚! | 泽语大叔

作者: 泽语大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-08 21:47:41 評論於
Review Speed: 12.0 | Submission Hit Rate: 25.0 Emphasis Research Direction: Tumor; Epigenetic Genetics Shared Experience: It has been a year since focusing on the Research series articles of this journal. The editorial department is thrilled to discover and adjust the direction, and there has been a significant increase in the research direction and regional distribution of the manuscript sources. Each issue also presents plenty of outstanding scientific research. Admittedly, some work may seem inferior to the Impact Factor, but overall, the journal is steadily improving. Wishing the magazine continued success!
(0) 讚! | 泽语大叔

作者: 上清奥雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 16:08:48 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0 Major research focus: Tumor; CAF experience sharing: Challenging
(0) 讚! | 上清奥雅

作者: Phoebe Law


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-05 21:07:43 評論於
What original data is included?
(0) 讚! | Phoebe Law

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/40)

開始撰寫 [Molecular Cancer] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*